Crucell Announces New Award of (Dollor) 110 Million for Paediatric Vaccine Quinvaxem(R) by UNICEF to Support Vaccination Program

British scientists claim to have developed a drug with the potential to 'vaccinate' those with a family history of bre

Comprehensive computational pipeline that integrates molecular and genetic analyses of tumors, along with T-cell targets, to design personalized cancer

medlinkInfants/medlink and young children are particularly vulnerable to meningitis, but experts on World Meningitis Day emphasize the importance

Advances in technology and manufacturing could boost the uptake of therapeutics derived from plants. Therapeutic proteins such as antibodies, hormones,

The U.S. Food and Drug Administration (USFDA) has released a new set of guidelines for the use of already approved Recombinant Human Papillomavirus 9-valent Vaccine in males.

Journal Editorial Report: He fought the law, and the law won. Image: Drew Angerer/Getty Images

A growing number of studies indicate Omicron is more resistant to current vaccines than previous Covid variants, though boosters seem to help. WSJ’s Daniela Hernandez gets an exclusive look inside a lab testing how antibodies interact with Omicron. Photo illustration: Tom Grillo

China got out ahead of the U.S. in shipping its Covid-19 vaccines around the world, but the Biden administration said it has donated more doses. WSJ examines how Omicron challenges both as they push for global influence. Photo: Rodrigo Sura/Esteban Biba/Shutterstock

Amid a surge in cases, some countries are handing out second booster shots. In Israel, early data suggest a fourth vaccine dose can increase antibodies against Covid-19, but not enough to prevent infections from Omicron. WSJ explains. Photo composite: Eve Hartley/WSJ

After Merck’s Covid-19 vaccine candidates failed, the drugmaker partnered with rival Johnson & Johnson. WSJ reporter Jared Hopkins takes us behind the scenes, as the first Merck-made shots are released for distribution. Photo: Hannah Yoon/WSJ

निर्देशक- विवेक अग्निहोत्रीकलाकार- नाना पाटेकर, पल्लवी जोशी, राइमा सेन, सप्तमी गौड़ा, अनुपम खेर, गिरिजा ओक "अगर मरना है तो लड़ के मरेंगे, आत्म निर्भर बन कर मरेंगे", भारतीय आयुर्विज्ञान अनुसंधान परिषद (ICMR) के महानिदेशक डा. बलराम भार्गव (नाना पाटेकर)

At one time the primary producers of the country’s vaccine requirements, the units are in terminal decline. Can they be revived?

Cambridge, MA. : National Bureau of Economic Research, 2023

Chennai accounted for nearly 21% of the non-vaccinated children, highlighting the gaps in an urban area and the need for targeted community outreach

The list reconfirms longstanding priorities for vaccine research and development: HIV, malaria, and tuberculosis -- three diseases that collectively kill nearly 2.5 million people each year

We need a coronavirus vaccine to beat the pandemic, but that's a problem. Why? Because making a Covid-19 vaccine that works (and is safe) will take a long time. Even the most hopeful estimates suggest it could take a year, but some believe we may have to wait until the end of 2021 to have a working cure, and that's before we tackle the problem of immunising the whole world. In this video we explore the challenges facing those looking to create a coronavirus vaccine, how human trials work and explain why developing a cure for coronavirus will take such a long time. This video was produced as part of Digital Society, a publishing partnership between WIRED and Vontobel where all content is editorially independent. Visit Vontobel Impact for more stories on how technology is shaping the future of society: https://www.vontobel.com/en-int/about-vontobel/impact/ Credits: Animation by RUN ZËBRA RUN http://runzebra.run/ Scientific animation by Microverse Studios https://www.microversestudios.com/

12 to 18 months is the timeline we keep hearing about for a potential Covid-19 vaccine. While this is possible, it would also be the fastest we've ever developed a vaccine. Dr. Seema Yasmin takes a look at the standard timeline for creating a vaccine, from the exploratory stage all the way until manufacturing and quality control. Just how does a Covid-19 vaccine fit into this timeline?

Dr. Seema Yasmin talks to three Covid-19 vaccine researchers who are developing three different types of vaccines. Traditionally, vaccines are created by using a weakened or dead version of the virus and injecting that into the body. Many of these developing coronavirus vaccines are using new technologies. What's the difference between recombinant protein-based vaccine, a DNA-based vaccine and an mRNA-based vaccine?

Dr. Jennifer Doudna, the coinventor of CRISPR, and Dr. Melissa Moore, Chief Scientific Officer of Moderna, discuss the rapid progress of developing a Covid vaccine using groundbreaking techniques, and what lies ahead for medical science research.

Dr. Nahid Bhadelia, founding director of the BU Center for Emerging Infectious Diseases Policy and Research (CEID), explores why vaccines haven’t always been getting to where they need to go during the Covid-19 pandemic.

The agency, however, warns that it’s not clear whether any of these will work against the deadly virus that has already killed over 4,800 people this year.

The company said the vaccine gives a 95.5% protection against severe dengue and an 80.3% reduction in the risk of hospitalisation.

They are designed to make a patient’s immune system attack tumours

It will be introduced in five districts of Bihar and Gujarat first.

Although the campaign ended on September 30, sources said government hospitals will continue to administer free doses till further orders

Indian vaccine manufacturers and regulators have changed the way they conceive, test and evaluate vaccines, emboldening them to apply emerging technologies to old diseases and experiment with new ways to inoculate

“Vaccines are the vital pillar of global health, and the IVMA mission is to ensure that every individual, regardless of where they live, has access to life-saving immuniszations” - Krishna Ella, Co-Founder, Executive Chairman of Bharat Biotech

The WHO has recognised TTS as a rare but serious adverse event linked to specific Covid-19 vaccines.

Pneubevax14   14 was found to be safe and induced robust and functional serotype specific immune responses to all 14 serotypes

Zydus Lifesciences’ ZyVac TCV receives WHO prequalification, eligible for U.N. procurement, combating typhoid fever in high-risk regions

Due to wide disparity in vaccine supply, of the 52 countries in Africa, 38 have given at least one dose to <5% of population

One million cases of human leptospirosis are reported every year resulting in an estimated 60,000 deaths

While most vaccines generate memory B-cells, not all of them turn into long-lasting plasma cells, and herein lies the rub

The pair hopes to stimulate the immune system to tackle tumors bearing mutant KRas proteins, one of cancer’s toughest targets

The first goal is to thwart the outbreak, but researchers also hope for new insights into combating the virus

Diversifying the portfolio of candidates is one of the most important steps